Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the

Yan Liu1, Yan Sun1, Xuze Lin2

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing 100029, China.

Vascular Pharmacology
|February 5, 2022
PubMed

Insights

Perivascular adipose tissue exosomes reduce foam cell formation via miR-382-5p and BMP4-PPARγ signaling, upregulating cholesterol transporters ABCA1 and ABCG1. This offers a novel therapeutic strategy for atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Adipose Tissue Biology

Background:

  • Perivascular adipose tissue (PVAT) releases exosomes (EXOs) that modulate vascular homeostasis.
  • PVAT-EXOs are known to reduce macrophage foam cell formation, but the precise molecular mechanisms require further elucidation.
  • This study investigates the role of microRNAs (miRNAs) within PVAT-EXOs in regulating macrophage cholesterol metabolism.

Purpose of the Study:

  • To investigate the role of PVAT-derived exosomes (EXOs) and their miRNA cargo in regulating macrophage cholesterol transport and foam cell formation.
  • To identify specific miRNAs involved in PVAT-EXO-mediated effects on cholesterol metabolism.
  • To elucidate the signaling pathways, including BMP4-PPARγ, involved in PVAT-EXO-mediated cholesterol efflux.

Main Methods:

  • RT-qPCR was used to quantify miR-382-5p levels in PVAT-EXOs from patients and mice.
  • Macrophage lipid accumulation was assessed using oil red O staining.
  • Cholesterol uptake, efflux, and the expression of cholesterol transporters (ABCA1, ABCG1) were evaluated following PVAT-EXO treatment and specific molecular interventions.

Main Results:

  • miR-382-5p levels were lower in PVAT-EXOs from coronary artery disease patients compared to healthy individuals.
  • PVAT-EXOs significantly reduced macrophage foam cell formation and enhanced cholesterol efflux.
  • Inhibition of miR-382-5p reversed the beneficial effects of PVAT-EXOs on foam cell formation and cholesterol efflux.
  • BMP4-PPARγ signaling was identified as a key pathway mediating the upregulation of ABCA1 and ABCG1 by PVAT-EXOs.

Conclusions:

  • PVAT-EXOs exert atheroprotective effects by reducing macrophage foam cell formation.
  • The mechanism involves miR-382-5p delivery via EXOs, which, along with BMP4-PPARγ signaling, upregulates ABCA1 and ABCG1 expression, promoting cholesterol efflux.
  • These findings highlight PVAT-EXOs as a potential therapeutic target for atherosclerosis prevention and treatment.